Related Experiment Video
Updated: Jun 27, 2025

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
Published on: February 23, 2024
Addressing transportation barriers in oncology: existing programs and new solutions
Sophia Pringle1, Emily M Ko2,3,4, Meredith Doherty3,4,5
1Leonard Davis Institute of Health Economics, Saint Joseph's University, Philadelphia, PA, USA.
Transportation access is a key barrier to cancer care and clinical trials. Addressing these needs through services and financial aid improves patient satisfaction, visit completion, and trial enrollment, especially for diverse populations.
Area of Science:
- Oncology
- Health Services Research
- Transportation Studies
Background:
- Transportation is a significant, yet often overlooked, barrier to accessing cancer care.
- This barrier particularly affects participation in clinical trials.
- Modifiable factors related to transportation can be addressed by healthcare providers, insurers, and health systems.
Purpose of the Study:
- To highlight transportation as a modifiable barrier in cancer care access.
- To emphasize the role of transportation interventions in improving clinical trial enrollment.
- To identify strategies for overcoming transportation challenges in oncology.
Main Methods:
- Review of existing literature and practices regarding transportation barriers in cancer care.
- Analysis of the impact of direct transportation services (e.g., ride-sharing, insurance-provided) on patient outcomes.
- Evaluation of patient financial reimbursement programs as a strategy to mitigate transportation barriers.
Main Results:
- Direct transportation services demonstrate high patient satisfaction and improve visit completion rates.
- Financial reimbursements can counteract transportation barriers, leading to increased clinical trial enrollment.
- These interventions are particularly beneficial for patients from low socioeconomic status and diverse racial/ethnic backgrounds.
Conclusions:
- Transportation interventions are crucial for enhancing access to cancer care and clinical trials.
- Addressing systemic, service, and knowledge gaps in transportation support can improve patient outcomes.
- Expanding transportation solutions is essential for equitable cancer care delivery and research participation.
Related Concept Videos
Treatment Resistant Cancers
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Barriers to Effective Communication II
Cultural barriers:
Differences in values, beliefs, religion, knowledge, and tradition can significantly impact communication. Awareness of nonverbal cues is critical, especially when conversing with a patient from a different culture. What appears appropriate in one culture may be inappropriate in another.
Semantic barriers:
As a result of their tendency to use...
Nonlinear Pharmacokinetics: Role of Transporters
Polymorphisms occurring in drug transporters can alter...
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...

